Prevalência de infecção por COVID-19 no sistema prisional no Espírito Santo/Brasil: pessoas privadas de liberdade e trabalhadores da justiça

Silva, Adriana Ilha da; Maciel, Ethel Leonor Nóia; Duque, Camila Leal Cravo; Gomes, Cristiana Costa; Bianchi, Erika; Cardoso, Orlei Amaral; Lira, Pablo Silva; Jabor, Pablo Medeiros; Zanotti, Raphael Lubiana; Tristão-Sá, Ricardo; Filho, Silvânio José de Souza Magno; Zandonade, Eliana

doi:10.1590/1980-549720210053

Cited by 5 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The same high prevalence was found in a study evaluating the percentage of SARS-CoV-2-infected inmates, health care professionals, and prison officers in prisons in Espírito Santo. Specifically, among 1830 individuals, the prevalence of COVID-19 infection was 11.89% among health care professionals, 22.07% among prison officers, and 31.64% among inmates[ 11 ].…”

Section: Discussionmentioning

confidence: 99%

Prevalence and features of SARS-CoV-2 infection in prisons in Tuscany

Stasi,

Pacifici,

Milli

et al. 2024

World J Exp Med

View full text Add to dashboard Cite

BACKGROUND Prisons can be a reservoir for infectious diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), due to the very intimate nature of the living spaces and the large number of people forced to share them. AIM To investigate the SARS-CoV-2 epidemiology in prisons, this study evaluated the infection incidence rate in prisoners who underwent nasopharyngeal swabs. METHODS This is an observational cohort study. Data collection included information on prisoners who underwent nasopharyngeal swab testing for SARS-CoV-2 and the results. Nasopharyngeal swab tests for SARS-CoV-2 were performed between 15 February 2021 and 31 May 2021 for prisoners with symptoms and all new arrivals to the facility. Another section included information on the diagnosis of the disease according to the International Classification of Diseases, Ninth Revision, and Clinical Modification. RESULTS Up until the 31 May 2021, 79.2% of the prisoner cohort (n = 1744) agreed to a nasopharyngeal swab test (n = 1381). Of these, 1288 were negative (93.3%) and 85 were positive (6.2%). A significant association [relative risk (RR)] was found only for the risk of SARS-CoV-2 infection among foreigners compared to Italians [RR = 2.4, 95% confidence interval (CI): 1.2-4.8]. A positive association with SARS-CoV-2 infection was also found for inmates with at least one nervous system disorder (RR = 4, 95%CI: 1.8-9.1). The SARS-CoV-2 incidence rate among prisoners is significantly lower than in the general population in Tuscany (standardized incidence ratio 0.7, 95%CI: 0.6-0.9). CONCLUSION In the prisoner cohort, screening and rapid access to health care for the immigrant population were critical to limiting virus transmission and subsequent morbidity and mortality in this vulnerable population.

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence and features of SARS-CoV-2 infection in prisons in Tuscany

Stasi,

Pacifici,

Milli

et al. 2024

World J Exp Med

View full text Add to dashboard Cite

show abstract

“…Esse cenário ressalta a importância da organização do fluxo de entrada e saída das pessoas nos presídios, assim como o trânsito de pessoas no ambiente interno. É preciso observar as normas de biossegurança dos protocolos de enfrentamento da Covid-19 e colocá-las em prática nos ambientes que têm essas características 17 .…”

Section: Discussionunclassified

Análise da vacinação contra Covid-19 na população privada de liberdade: estudo ecológico

Rocha,

Santos,

Lucena

et al. 2024

Rev. enferm. UERJ

View full text Add to dashboard Cite

Objetivo: analisar o cenário de vacinação contra Covid-19 na população privada de liberdade em um estado do Nordeste brasileiro. Método: estudo do tipo observacional e ecológico, com os dados extraídos do Sistema de informações penitenciário brasileiro e dos boletins publicados pelo Conselho Nacional de Justiça, referentes a outubro de 2021 a junho de 2022, submetidos à análise estatística descritiva, por meio de frequências absolutas e relativas. Resultados: verificou-se que, entre 4.345 pessoas privadas de liberdade com a primeira dose de vacinação contra Covid-19, apenas 573 possuíam a segnda dose e nenhuma a terceira dose. Conclusão: evidenciou-se que, apesar da vacinação ser um benefício, ainda é um grande desafio para ser implementada para a população privada de liberdade, visto que, mesmo sendo considerados grupos prioritários, o acesso a esse direito foi prejudicado para esses indivíduos.

show abstract

“…Prisons can be epicentres of various infectious diseases due to a combination of risk factors favouring transmission, including barriers to implement social distancing related to overcrowding (Kinner et al , 2020). To date, many prisons have reported a high prevalence rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and overcrowding is associated with increased incidence rates of COVID-19 (Leibowitz et al , 2021; Duque et al , 2022; Kennedy et al , 2020; Kronfli et al , 2022; Silva et al , 2021). By 18 May 2021, 2,680 COVID-19 deaths were reported in US prisons (Hagan et al , 2020; The Marshall Project, 2021).…”

Section: Introductionmentioning

confidence: 99%

SARS-CoV-2 seroprevalence study after the first wave among persons living and working in an overcrowded Swiss prison

Gétaz

Wolff²,

Gonçalves³

et al. 2022

IJPH

View full text Add to dashboard Cite

Purpose Prisons can be epicentres of infectious diseases. However, empirical evidence on the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in prison is still scarce. This study aims to estimate the seroprevalence rates of anti-SARS-CoV-2 in the largest and most crowded Swiss prison and compare them with the seroprevalence rate in the general population. Design/methodology/approach A cross-sectional study was conducted in June 2020, one month after the first wave of SARS-CoV-2 in Switzerland. Groups included: people living in detention (PLDs) detained before the beginning of the pandemic (n = 116), PLDs incarcerated after the beginning of the pandemic (n = 61), prison staff and prison healthcare workers (n = 227) and a sample from the general population in the same time period (n = 3,404). The authors assessed anti-SARS-CoV-2 IgG antibodies. Findings PLDs who were incarcerated before the beginning of the pandemic had a significantly lower seroprevalence rate [0.9%, confidence interval (CI)95%: 0.1%–5.9%] compared to the general population (6.3%, CI 95%: 5.6–7.3%) (p = 0.041). The differences between PLDs who were incarcerated before and other groups were marginally significant (PLDs incarcerated after the beginning of the pandemic: 6.6%, CI 95%: 2.5%–16.6%, p = 0.063; prison staff CI 95%: 4.8%, 2.7%–8.6%, p = 0.093). The seroprevalence of prison staff was only slightly and non-significantly lower than that of the general population. Originality/value During the first wave, despite overcrowding and interaction with the community, the prison was not a hotspot of SARS-CoV-2 infection. Preventive measures probably helped avoiding clusters of infection. The authors suggest that preventive measures that impact social welfare could be relaxed when overall circulation in the community is low to prevent the negative impact of isolation.

show abstract

Prevalência de infecção por COVID-19 no sistema prisional no Espírito Santo/Brasil: pessoas privadas de liberdade e trabalhadores da justiça

Cited by 5 publications

References 5 publications

Prevalence and features of SARS-CoV-2 infection in prisons in Tuscany

Prevalence and features of SARS-CoV-2 infection in prisons in Tuscany

Análise da vacinação contra Covid-19 na população privada de liberdade: estudo ecológico

SARS-CoV-2 seroprevalence study after the first wave among persons living and working in an overcrowded Swiss prison

Contact Info

Product

Resources

About